582 related articles for article (PubMed ID: 21651944)
41. A novel multi-antigen virally vectored vaccine against Mycobacterium avium subspecies paratuberculosis.
Bull TJ; Gilbert SC; Sridhar S; Linedale R; Dierkes N; Sidi-Boumedine K; Hermon-Taylor J
PLoS One; 2007 Nov; 2(11):e1229. PubMed ID: 18043737
[TBL] [Abstract][Full Text] [Related]
42. Blocking the mitogen activated protein kinase-p38 pathway is associated with increase expression of nitric oxide synthase and higher production of nitric oxide by bovine macrophages infected with Mycobacterium avium subsp paratuberculosis.
Souza CD
Vet Immunol Immunopathol; 2015 Mar; 164(1-2):1-9. PubMed ID: 25700780
[TBL] [Abstract][Full Text] [Related]
43. Efficacy of novel lipid-formulated whole bacterial cell vaccines against Mycobacterium avium subsp. paratuberculosis in sheep.
Griffin JF; Hughes AD; Liggett S; Farquhar PA; Mackintosh CG; Bakker D
Vaccine; 2009 Feb; 27(6):911-8. PubMed ID: 19059295
[TBL] [Abstract][Full Text] [Related]
44. Attenuated Salmonella secreting Brucella protective antigens confer dual-faceted protection against brucellosis and salmonellosis in a mouse model.
Senevirathne A; Hewawaduge C; Lee JH
Vet Immunol Immunopathol; 2019 Mar; 209():31-36. PubMed ID: 30885303
[TBL] [Abstract][Full Text] [Related]
45. Paradigm redux--Mycobacterium avium subspecies paratuberculosis-macrophage interactions show clear variations between bovine and human physiological body temperatures.
Lamont EA; Sreevatsan S
Microb Pathog; 2010 May; 48(5):143-9. PubMed ID: 20188816
[TBL] [Abstract][Full Text] [Related]
46. The Effect of Inactivated Mycobacterium Paratuberculosis Vaccine on the Response to a Heterologous Bacterial Challenge in Pigs.
Jensen KJ; Hansen MS; Heegaard PMH; Benn CS; Jungersen G
Front Immunol; 2019; 10():1557. PubMed ID: 31333678
[No Abstract] [Full Text] [Related]
47. A bovine macrophage screening system for identifying attenuated transposon mutants of Mycobacterium avium subsp. paratuberculosis with vaccine potential.
Scandurra GM; Young M; de Lisle GW; Collins DM
J Microbiol Methods; 2009 Apr; 77(1):58-62. PubMed ID: 19386227
[TBL] [Abstract][Full Text] [Related]
48. Bovine paratuberculosis: recent advances in vaccine development.
Santema W; Rutten V; Koets A
Vet Q; 2011 Dec; 31(4):183-91. PubMed ID: 22077785
[TBL] [Abstract][Full Text] [Related]
49. Cell-mediated and humoral immune responses after immunization of calves with a recombinant multiantigenic Mycobacterium avium subsp. paratuberculosis subunit vaccine at different ages.
Thakur A; Aagaard C; Stockmarr A; Andersen P; Jungersen G
Clin Vaccine Immunol; 2013 Apr; 20(4):551-8. PubMed ID: 23389934
[TBL] [Abstract][Full Text] [Related]
50. Efficacy, immune responses and side-effects of vaccines against Johne's disease in young red deer (Cervus elaphus) experimentally challenged with Mycobacterium avium subsp paratuberculosis.
Mackintosh CG; Labes RE; Thompson BR; Clark RG; de Lisle GW; Johnstone PD; Griffin JF
N Z Vet J; 2008 Feb; 56(1):1-9. PubMed ID: 18322553
[TBL] [Abstract][Full Text] [Related]
51. Immunogenicity and protective efficacy of the Mycobacterium avium subsp. paratuberculosis attenuated mutants against challenge in a mouse model.
Chen JW; Faisal SM; Chandra S; McDonough SP; Moreira MA; Scaria J; Chang CF; Bannantine JP; Akey B; Chang YF
Vaccine; 2012 Apr; 30(19):3015-25. PubMed ID: 22107851
[TBL] [Abstract][Full Text] [Related]
52. Superior Protection from Live-Attenuated Vaccines Directed against Johne's Disease.
Shippy DC; Lemke JJ; Berry A; Nelson K; Hines ME; Talaat AM
Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27806993
[TBL] [Abstract][Full Text] [Related]
53. The within host dynamics of Mycobacterium avium ssp. paratuberculosis infection in cattle: where time and place matter.
Koets AP; Eda S; Sreevatsan S
Vet Res; 2015 Jun; 46(1):61. PubMed ID: 26092382
[TBL] [Abstract][Full Text] [Related]
54. Developing smarter vaccines for paratuberculosis: From early biomarkers to vaccine design.
de Silva K
Immunol Rev; 2021 May; 301(1):145-156. PubMed ID: 33619731
[TBL] [Abstract][Full Text] [Related]
55. Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.
Kahl-McDonagh MM; Arenas-Gamboa AM; Ficht TA
Infect Immun; 2007 Oct; 75(10):4923-32. PubMed ID: 17664263
[TBL] [Abstract][Full Text] [Related]
56. A peptide-based vaccine for Mycobacterium avium subspecies paratuberculosis.
Abdellrazeq GS; Elnaggar MM; Bannantine JP; Schneider DA; Souza CD; Hwang J; Mahmoud AHA; Hulubei V; Fry LM; Park KT; Davis WC
Vaccine; 2019 May; 37(21):2783-2790. PubMed ID: 31003915
[TBL] [Abstract][Full Text] [Related]
57. Vaccination against paratuberculosis of lambs already infected experimentally with Mycobacterium avium subspecies paratuberculosis.
Gwozdz JM; Thompson KG; Manktelow BW; Murray A; West DM
Aust Vet J; 2000 Aug; 78(8):560-6. PubMed ID: 10979513
[TBL] [Abstract][Full Text] [Related]
58. Facts, myths and hypotheses on the zoonotic nature of Mycobacterium avium subspecies paratuberculosis.
Atreya R; Bülte M; Gerlach GF; Goethe R; Hornef MW; Köhler H; Meens J; Möbius P; Roeb E; Weiss S;
Int J Med Microbiol; 2014 Oct; 304(7):858-67. PubMed ID: 25128370
[TBL] [Abstract][Full Text] [Related]
59. Responses of Bovine Innate Immunity to Mycobacterium avium subsp. paratuberculosis Infection Revealed by Changes in Gene Expression and Levels of MicroRNA.
Malvisi M; Palazzo F; Morandi N; Lazzari B; Williams JL; Pagnacco G; Minozzi G
PLoS One; 2016; 11(10):e0164461. PubMed ID: 27760169
[TBL] [Abstract][Full Text] [Related]
60. Systems Biology Analysis of Temporal
Rossetti CA; Drake KL; Lawhon SD; Nunes JS; Gull T; Khare S; Adams LG
Front Microbiol; 2017; 8():1275. PubMed ID: 28798726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
